Opens in a new tab

Angelalign Technology v Align Technology (CoA, 8 July 2026)

Date8 July 2026
CourtCoA
DivisionLuxembourg (LU)
Type of actionAppeal RoP220.1
Registry referenceUPC-CoA-36/2026
PartiesAngelalign Technology Inc., Angelalign France Technology SASU, Angelalign Technology (Germany) GmbH, Italy Angelalign Technology S.R.L., Sh…

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In an order of 8 July 2026 (UPC_CoA_36/2026), the Court of Appeal (Judges Voß, presiding, van den Broek, rapporteur, Sabotier, and technically qualified Judges Philipps and Sanchini) holds admissible but unfounded the appeal of Angelalign Technology and four group companies against the provisional measures order of the Düsseldorf Local Division of 12 February 2026 (UPC_CFI_723/2025), granted to Align Technology on unitary patent EP 4 346 690 (automated management of clinical modifications to an orthodontic aligner treatment plan). The provisional measures are maintained (paragraph 187).

The order matters for practice on two points: the Court of Appeal is not bound by the first-instance exclusion of late arguments and decides for itself under Rule 222.2, and the necessity of the measures is assessed by reference to direct competition and market position, without any requirement of irreparable harm.

Facts and procedure

On Align’s application, the Düsseldorf Local Division found jurisdiction, urgency, likely validity of claims 1, 13 and 15 and infringement, since infringement had not been contested in time, and granted an injunction for direct infringement of claims 1 and 13 and indirect infringement of claim 15, with an interim award of costs of EUR 400,000. By an order of 16 December 2025 it had disregarded paragraphs 13 to 24 of the rejoinder and exhibit AR07, the Court of Appeal dismissed a request for discretionary review on 6 January 2026. Angelalign appealed on 27 February 2026, the hearing took place on 18 June 2026. The patent is under opposition at the EPO.

The applicable law

The Court applies Art. 62 UPCA and Rules 205, 206.2(c) and 211 on provisional measures, Rule 222.2 on new submissions on appeal, Arts. 54 and 69 EPC and the Protocol on the Interpretation of Art. 69, and Art. 71b of Regulation 1215/2012 on international jurisdiction.

Question

Are the claims likely to be valid and infringed, may the Court of Appeal admit non-infringement arguments excluded as late at first instance, and are the provisional measures necessary?

Decision

The UPC has jurisdiction over all appellants (paragraph 22). Features 1.6 (determination against a threshold) and 1.7 (generation of the revised plan) are two distinct steps with a specific temporal order (paragraph 56). Exhibits AR09 and AR10, filed late without explanation and raising a new invalidity attack, are disregarded (paragraphs 61 to 65). The claims are held more likely than not to be valid: neither D2 nor D6 anticipates the invention, and no combination starting from D1, D2, D6 or D7 renders it obvious (paragraphs 57 to 156).

On infringement, the Court is not bound by the exclusion ordered at first instance and exercises its own discretion (paragraph 159). The arguments on scenario 1, on file since the rejoinder of 28 November 2025, are admitted, those on scenarios 2 and 3, late and unjustified, are disregarded (paragraphs 160 to 164). Direct infringement of claims 1 and 13 and indirect infringement of claim 15 by the iOrtho software and the aligners is held more likely than not (paragraph 173). Urgency is not disputed (paragraph 175). Irreparable harm is not required. Between direct competitors, the concrete risk to Align’s market position justifies the measures, and the balance of interests favours Align, since the appellants can market iOrtho without the feature at issue (paragraphs 178 to 186). The provisional measures ordered by the Local Division are maintained (paragraph 187). The order dismisses the appeal and orders the appellants to bear the costs of the appeal under Art. 69(1) UPCA: the exclusion of the arguments on scenarios 2 and 3 does not alter this, and the first instance rejection of the claims against the third defendant, which was not appealed, is final, including as to costs (paragraphs 188 and 189).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts. 33(1)(b), 62, 69(1) and 75(1)
Rules of Procedure
Rules 205, 206.2, 209.1, 211 and 222.2
European Patent Convention
Art. 54, Art. 69
Regulation (EU) No 1215/2012
Arts. 7(2) and 71b
Case law cited
NanoString v 10x Genomics, Court of Appeal, 26 February 2024, VusionGroup v Hanshow, Court of Appeal, 13 May 2024, Mammut v Ortovox, Court of Appeal, 25 September 2024, Abbott v Sibio, Court of Appeal, 14 February 2025, Insulet v EOFlow, Court of Appeal, 30 April 2025 (UPC_CoA_768/2024), Meril v Edwards, Court of Appeal, 25 November 2025 (UPC_CoA_646/2024), Amgen v Sanofi, Court of Appeal, 25 November 2025, Amgen v Regeneron, Court of Appeal, 25 November 2025

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.
First instance cited in the decision: UPC_CFI_723/2025

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 6 November 2025 Align v Angelalign (CFI, 6 November 2025) Application for provisional measures · UPC_CFI_723/2025

    La demande de garantie des frais contre Align Technology est rejetée : les défenderesses n'invoquent pas sa situation financière et ne prouvent pas le droit américain, une constatation faite dans une autre affaire ne pouvant être transposée.

  2. 29 December 2025 Align v Angelalign (CFI, 29 December 2025) Application for provisional measures · UPC_CFI_723/2025

    L'autorisation de faire appel de l'ordonnance écartant des arguments tardifs et refusant des écritures supplémentaires est refusée, cette ordonnance relevant du pouvoir d'appréciation de la formation et des circonstances de l'espèce.

  3. 12 February 2026 Align Technology v Angelalign Technology (CFI, 12 February 2026) Application for provisional measures · UPC_CFI_723/2025

    Une injonction provisoire est prononcée sur EP 4 346 690 contre cinq sociétés Angelalign, sans garantie. La charge de la preuve de la nullité reste au défendeur et la holding, sans acte propre allégué, est mise hors de cause.

  4. 3 July 2026 Align Technology v Angelalign Technology (CFI, 3 July 2026) Application for provisional measures · UPC_CFI_723/2025

    Les défenderesses 1, 2, 4, 5 et 6 doivent payer à la juridiction une astreinte de 49 500 € pour avoir laissé en ligne, 33 jours après le délai d’exécution, un manuel d’utilisation et des publications constituant des offres prohibées.

What the record states

Nature of the act
Appeal RoP220.1
Outcome (Dhenne Avocats summary)
La cour d’appel juge l’appel d’Angelalign recevable mais mal fondé : les revendications 1, 13 et 15 de EP 4 346 690 sont vraisemblablement valables et contrefaites, et les mesures provisoires sont maintenues.
Appeal
Decision of the Court of Appeal (first instance cited: UPC_CFI_723/2025).
Instance
Court of Appeal decision.

Patents mentioned

  • EP 4 346 690 mentioned in: summary of the decision, Dhenne Avocats analysis Follow this patent

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 346 690Patent at issue according to the summary or official headnote
Also mentioned in 5 other decision(s): Align Technology v Angelalign Technology (CFI, 12 February 2026) · Align Technology v Angelalign Technology (CFI, 3 July 2026) · Angelalign Technology v Align Technology (CoA, 6 January 2026) · Align v Angelalign (CFI, 29 December 2025) · Align v Angelalign (CFI, 6 November 2025)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: summary of the decision, Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.